close
close

HIG Capital announces the sale of Deenova Srl

Posted on by Lucas
HIG Capital announces the sale of Deenova Srl

MILAN, 21. November 2024 /PRNewswire/ — HIG Capital (“HIG”), a leading global alternative investment firm 66 billion dollars of capital under management, is pleased to announce that a subsidiary has signed a definitive agreement to sell its portfolio company Deenova Srl (“Deenova” or the “Company”), a leading Italian company in the traceability of pharmaceuticals and medical devices in Europe hospitals. The company will be purchased by Equiter Infrastructure II, a fund managed by Ersel Asset Management SGR, and Amundi Private Equity Italia (“APEI”) in collaboration with the founder of Deenova Sergio Giglio. Completion of the transaction is subject to customary regulatory approvals.

Since 2004, Deenova has been providing value-added automation and traceability services to hospitals by developing, implementing and operating automatic distribution and traceability systems for medicines and medical devices. Deenova represents a long-term partner solution for hospitals by implementing systems fully integrated into the hospital infrastructure, guaranteeing significant benefits in terms of patient safety, cost savings and process optimization.

Since its initial investment, HIG has supported Deenova’s international growth through strategic acquisitions and strengthening the management team. The company has become an industry leader across Europe and is currently present in approximately 100 hospitals in Italy, France, the United Kingdom, MaltaGermany, Spain and Poland represented.

Raffaele LegnaniManaging Director and Head of HIG. He commented in Italian: “We are proud to have supported Deenova’s growth strategy, which has enabled the company to become a European leader in the traceability and management of medicines and medical devices.” We are very proud, Having positioned Deenova for significant and sustained future growth. We are also proud of the return our investors achieved with this transaction.”

Giorgio PavesiCEO by Deenovaadded: “The partnership with HIG has been fundamental in accelerating Deenova’s international development through organic and inorganic growth initiatives.” The result is that the company is now ranked in the reference industry for excellence in hospital services in Europe.